STAR Quarterly Results, Profit & Loss, Balance Sheet (STAR)
STAR quarterly results and annual financials: sales, operating profit, OPM, net profit, EPS, balance sheet, cash flow and ratios like ROCE, with YoY and QoQ growth.
Strides Pharma Science Ltd reported sales of ₹1,430 Cr, operating profit of ₹251 Cr (OPM 18%) and net profit of ₹134 Cr for the quarter ended Sep 2026. Figures in ₹ crore, consolidated where available.
STAR quarterly results (₹ Cr)
Metric
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Sales
1,154
1,190
1,120
1,221
1,195
1,323
1,265
1,430
Expenses
943
973
902
990
959
1,084
1,037
1,179
Operating Profit
210
218
218
231
236
240
228
251
OPM
18%
18%
19%
19%
20%
18%
18%
18%
Other Income
4
-12
0
18
104
3
68
3
Interest
52
50
47
46
43
42
41
47
Depreciation
48
49
49
50
51
53
56
57
Profit before tax
114
106
122
153
245
148
200
150
Tax
21%
20%
13%
14%
15%
13%
17%
11%
Net Profit
90
86
106
132
208
129
165
134
EPS in Rs
9.54
8.91
10.8
13.84
21.93
13.77
17.02
14.2
STAR profit & loss, annual (₹ Cr)
Metric
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
TTM
Sales
3,070
3,688
3,890
4,565
4,859
5,213
Expenses
3,201
3,544
3,362
3,763
3,933
4,258
Operating Profit
-131
145
528
803
925
955
OPM
-4.3%
3.9%
14%
18%
19%
18%
Other Income
-112
92
-100
3,313
124
178
Interest
177
261
280
249
179
172
Depreciation
233
243
214
192
202
217
Profit before tax
-653
-268
-65
3,675
669
744
Tax
-27%
-21%
45%
2%
14%
-
Net Profit
-474
-212
-94
3,598
575
637
EPS in Rs
-51.25
-22.44
-7.68
389.75
60.34
66.92
Dividend Payout
0%
-7%
-33%
1%
8%
-
STAR balance sheet (₹ Cr)
Metric
Mar 2024
Mar 2025
Sep 2025
Mar 2026
Sep 2026
Equity Capital
92
92
92
92
92
Reserves
2,034
2,460
2,664
3,015
3,324
Borrowings
2,517
1,880
1,844
1,758
1,905
Other Liabilities
1,157
1,498
1,921
1,941
2,167
Total Liabilities
5,799
5,929
6,521
6,807
7,489
Fixed Assets
1,865
1,899
2,139
2,101
2,406
CWIP
162
207
164
447
226
Investments
303
409
440
291
346
Other Assets
3,470
3,414
3,777
3,967
4,510
Total Assets
5,799
5,929
6,521
6,807
7,489
STAR cash flows (₹ Cr)
Metric
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Cash from Operating Activity
-258
44
701
684
703
Cash from Investing Activity
-119
302
-150
-90
-173
Cash from Financing Activity
421
-214
-693
-643
-453
Net Cash Flow
45
133
-142
-48
76
Free Cash Flow
-326
-43
672
505
291
CFO/OP
199%
-30%
128%
77%
84%
CFO/EBITDAShare of operating profit converting into cash: CFO (before tax) / Operating Profit